Register Now: From Clinical to Commercial: Accelerating ADC Late-Stage Development with Technology Innovation and Integrated Platform
|Articles|August 11, 2015

Self-Contained Laboratory Homogenizer Prepares Injectable Drugs

GEA's self-contained homogenizer is designed for laboratory applications, including cell dispersions.

 

GEA's Pony NS2006L is a self-contained, high-pressure laboratory homogenizer for product development of advanced fluid applications, including nanoparticles, nanodispersions, nanoemulsions, and cell dispersions. The homogenizers can reduce particle sizes down to nanometer range for the preparation of injectable drugs.

The homogenizer is designed for continuous operation up to 1500 bar. The sanitary design is suited for clean-in-place and sterilization-in-place. The Pony NS2006L achieves the same results as larger size homogenizers, and its compact design allows easy installation with simple operation and quick maintenance. It is also suitable for viscous products.

Source: GEA


Related to this article

The BioPharm Brief: FDA’s Fast-Track Pilot Reportedly Stalls, a Long-Acting Bispecific for Atopic Dermatitis, and a Twice-Yearly Obesity Approach
FDA has reportedly shelved its Commissioner’s National Priority Voucher pilot and paused publishing complete response letters, Zai Lab’s IL-13/IL-31Rα bispecific ZL-1503 shows a 40- to 50-day half-life that points to dosing every 12 weeks, and Wave Life Sciences reports 1-year INLIGHT data for its INHBE-silencing siRNA WVE-007 in obesity.